IRON
Price
$62.16
Change
+$0.67 (+1.09%)
Updated
Sep 23 closing price
Capitalization
2.16B
43 days until earnings call
SYRE
Price
$16.02
Change
+$0.73 (+4.77%)
Updated
Sep 23 closing price
Capitalization
967.62M
43 days until earnings call
Interact to see
Advertisement

IRON vs SYRE

Header iconIRON vs SYRE Comparison
Open Charts IRON vs SYREBanner chart's image
Disc Medicine
Price$62.16
Change+$0.67 (+1.09%)
Volume$327.72K
Capitalization2.16B
Spyre Therapeutics
Price$16.02
Change+$0.73 (+4.77%)
Volume$943.94K
Capitalization967.62M
IRON vs SYRE Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. SYRE commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (IRON: $62.16 vs. SYRE: $16.02)
Brand notoriety: IRON and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 96% vs. SYRE: 176%
Market capitalization -- IRON: $2.16B vs. SYRE: $967.62M
IRON [@Biotechnology] is valued at $2.16B. SYRE’s [@Biotechnology] market capitalization is $967.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 5 bullish, 2 bearish.
  • SYRE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IRON is a better buy in the short-term than SYRE.

Price Growth

IRON (@Biotechnology) experienced а +3.02% price change this week, while SYRE (@Biotechnology) price change was +8.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.16B) has a higher market cap than SYRE($968M). IRON YTD gains are higher at: -1.956 vs. SYRE (-31.186). IRON has higher annual earnings (EBITDA): -142.42M vs. SYRE (-222.15M). IRON has more cash in the bank: 650M vs. SYRE (527M). SYRE has less debt than IRON: SYRE (0) vs IRON (30.9M). IRON (0) and SYRE (0) have equivalent revenues.
IRONSYREIRON / SYRE
Capitalization2.16B968M223%
EBITDA-142.42M-222.15M64%
Gain YTD-1.956-31.1866%
P/E RatioN/A1.68-
Revenue00-
Total Cash650M527M123%
Total Debt30.9M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
21

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONSYRE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 27 days ago
81%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRCRX9.740.08
+0.83%
NYLI CBRE Real Estate Class C
PNRCX48.300.29
+0.60%
PGIM Jennison Natural Resources C
NBPBX50.720.19
+0.38%
Neuberger Berman Large Cap Value Adv
FSCDX29.86N/A
N/A
Fidelity Advisor Small Cap A
LIGCX11.69-0.11
-0.93%
Loomis Sayles International Growth C

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+1.08%
SYRE - IRON
53%
Loosely correlated
+4.77%
CGON - IRON
51%
Loosely correlated
-0.92%
XNCR - IRON
50%
Loosely correlated
-0.67%
CRNX - IRON
50%
Loosely correlated
+6.35%
KMSTF - IRON
49%
Loosely correlated
N/A
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+4.77%
CGON - SYRE
59%
Loosely correlated
-0.92%
IDYA - SYRE
59%
Loosely correlated
+0.04%
XNCR - SYRE
57%
Loosely correlated
-0.67%
CRNX - SYRE
56%
Loosely correlated
+6.35%
BEAM - SYRE
55%
Loosely correlated
-2.79%
More